1. Home
  2. UAMY vs NNNN Comparison

UAMY vs NNNN Comparison

Compare UAMY & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$9.04

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$35.79

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAMY
NNNN
Founded
1968
2021
Country
United States
Germany
Employees
N/A
27
Industry
Metal Fabrications
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
UAMY
NNNN
Price
$9.04
$35.79
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.44
N/A
AVG Volume (30 Days)
12.5M
14.9K
Earning Date
05-11-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,257,708.00
N/A
Revenue This Year
$219.89
N/A
Revenue Next Year
$104.28
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
162.80
N/A
52 Week Low
$1.94
$7.76
52 Week High
$19.71
$55.65

Technical Indicators

Market Signals
Indicator
UAMY
NNNN
Relative Strength Index (RSI) 46.69 66.80
Support Level $7.45 $26.31
Resistance Level $11.15 $38.00
Average True Range (ATR) 0.76 3.05
MACD -0.06 0.67
Stochastic Oscillator 45.67 91.60

Price Performance

Historical Comparison
UAMY
NNNN

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: